Apr 20, 2021

New J&J partnership could save NHS £1.6m a year

Leila Hawkins
2 min
New J&J partnership could save NHS £1.6m a year
The partnership between Johnson & Johnson-owned DePuy Synthes and Open Medical could save the NHS up to £1.6 million a year by reducing trauma admissio...

DePuy Synthes, the orthopaedic arm of Johnson & Johnson, has entered into a partnership with British digital healthcare company Open Medical Ltd, with the aim of enhancing digital patient care pathways in trauma and orthopaedic surgery within the National Health Service (NHS). 

As a result of the partnership, healthcare providers using DePuy Synthes’ surgical products will also be able to make use of Open Medical’s PathpointTM eTrauma platform, alongside its orthopaedic medical device technology, as part of the companies' value-based healthcare solutions. 

The Pathpoint eTrauma platform is a cloud-based clinical coordination platform, replacing whiteboards, notebooks and paper lists with digital tools to provide a more centralised, streamlined system. By using this new platform, providers hope to improve patient triage and tracking, and improve data capture through its use of advanced natural language processing. 

It is also hoped this will lead to efficiency savings, with Open Medical saying that PathpointTM eTrauma saves up to 20 hours of clinicians time per month, reducing the costs of inpatient episodes by up to £1.6 million a year. 

In line with the NHS' plan to increase the range of digital services it offers, the partnership will enable providers and clinicians to deliver digital transformation of existing care pathways. 

Gavin Meadows, Trauma Business Unit Director at DePuy Synthes GB, said: “For more than a year now the NHS has faced unprecedented capacity and resource challenges as a result of COVID-19. During the pandemic, DePuy Synthes Trauma sought to respond purposefully in bringing new technologies to our customers that support the optimisation and streamlining of patient care whilst protecting outcomes, and our partnership with Open Medical is an exciting example of this.” 

Commenting on the partnership, Michael Shenouda, Medical Director at Open Medical Ltd, said, “This is a fantastic opportunity to partner with the world’s leading medical devices company, to really enhance the service we can deliver to patient care providers. 

"The collaboration will allow clinicians to manage their patient pathways through innovative solutions, using the latest technology in both medical implants and software services, ensuring that patients receive the best care, in a timely and efficient manner, and with evidence-based technology. We hope that the collaboration will increase accessibility to solutions that have been demonstrated to improve patient care and outcomes”.

Share article

Jun 24, 2021

Data de-identification - why it matters in healthcare

3 min
Riddhiman Das, co-founder and CEO of data privacy startup TripleBlind tells us why data de-identification is important in the healthcare sector

Large amounts of healthcare data is generated yet goes unused due to privacy concerns. To address this, data privacy firm TripleBlind has created Blind De-identification, a new approach that allows healthcare organisations to use patient data while eliminating the possibility of the user learning anything about the patient’s identity. 

We asked Riddhiman Das, co-founder and CEO to tell us more about data de-identification. 

Why is data de-identification important in healthcare? 
Blind De-identification allows every attribute of any given dataset to be used, even at an individual level, while being compliant to privacy laws, rules, and regulations by default.

Governments around the world are adopting global data privacy and residency laws like GDPR, which prohibit citizens’ personally identifiable information data from leaving the borders of the country. While great for data protection, data residency laws result in global silos of inaccessible data. TripleBlind allows computations to be done on enterprise-wise global data, while enforcing data residency regulations. 

In the US, HIPAA compliance has relied on what is called the Safe Harbor method, which requires removing 18 types of personal patient identifiers like names, email addresses, and medical record numbers. The Safe Harbor method can be too restrictive with the data or can leave too many indirect identifiers, which puts the patient data security at risk. Getting de-identification wrong could make an organisation liable for a costly mistake.

What does TripleBlind's solution do? 
With TripleBlind, data is legally de-identified in real time with practically 0% probability of re-identification. Our solution allows analytics on data containing personally identifiable information and protected health information  with zero possibility of re-identifying an individual from the dataset. This allows healthcare organisations to access more meaningful data, creating more accurate and less biased results.

For example, a healthcare drug researcher in a rural, predominantly white area, would only have patient data that would reflect their local population. With TripleBlind’s de-identification, they could more easily leverage third-party data from another healthcare facility in a more diverse region, creating a more complete data set that more accurately reflects the larger population. This has the possibility to create more accurate diagnoses and better drug results for more diverse populations.

How can healthcare organisations use this in practice? 
TripleBlind is blind to all data and algorithms. That means we never take possession of customer data. We only route traffic between entities, enforce permissions, and provide audit trails. The enterprise’s data remains under their control. TripleBlind does not host, copy or control their data, algorithms or other information assets, ever. 

We facilitate a connection to an encrypted version of their information assets. Our technology allows the algorithms and data to interact in an encrypted space that only exists for the duration of the operation. Organisations use their existing infrastructure, so it’s not hardware dependent.

Share article